Notatki do odcinka
This Podcast is an interview with Michael Baker, CEO and Managing Director of Arovella Therapeutics , a biotechnology company focused on developing cell therapies for cancer treatment. Michael discusses his background, transitioning from a research scientist to venture capital and then joining Arovella in 2020. He explains Arovella's work on CAR-iNKT cell therapies, which involve genetically reprogramming a patient's immune cells to target and kill cancer cells.
Michael highlights the advantages of Arovella's approach over traditional CAR-T cell therapies, including faster manufacturing…
Strona: podcasters.spotify.com

